Novartis | Egenkapital Og Reserver



Equity Capital And Reserves Endring Dato
AbbVie USD 3.32B 2.71B 2024-12
Alcon AG USD 21.55B 164M 2024-12
Almirall EUR 1.49B 10.37M 2024-06
Amgen USD 5.88B 1.65B 2024-12
AstraZeneca USD 41.04B 168M 2025-03
Autolus Therapeutics Ltd 427.32M 49.64M 2024-12
Bayer EUR 32.04B 1.49B 2024-12
Biogen USD 16.72B 357.1M 2024-12
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Fresenius EUR 19.54B 715M 2024-12
Fresenius Medical Care EUR 14.58B 214.44M 2024-12
Galapagos EUR 2.75B 149.05M 2025-03
Genmab DKK 36.7B 4.78B 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
GRIFOLS EUR 5.88B 533.83M 2024-12
Hikma Pharmaceutical USD 2.29B 88M 2024-06
J&J USD 78.11B 6.62B 2025-03
Lonza CHF 9.33B 23M 2024-12
Merck EUR 29.99B 1.66B 2024-12
Merck USD 46.31B 1.81B 2024-12
Novartis USD 44.05B 605M 2024-12
Novartis USD 44.05B 729M 2024-12
Novo Nordisk 120.52B 8B 2024-09
Orion EUR 1.07B 61.8M 2025-03
Pfizer USD 88.2B 4.08B 2024-12
Philips EUR 12.01B 87M 2024-12
Recordati EUR 1.88B 694K 2024-12
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 74.07B 3.78B 2025-03
UCB EUR 10.03B 1.08B 2024-12



Novartis Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.